Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer
Hua Su, Chao Peng, Yang Liu
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 20
Immune checkpoint inhibitors: breakthroughs in cancer treatment
Xueqing Kong, Jinyi Zhang, Shuwei Chen, et al.
Cancer Biology and Medicine (2024), pp. 1-11
Open Access | Times Cited: 18
Correlation of PTEN signaling pathway and miRNA in breast cancer
Mahya Mohammadi, Ahmad Fazilat, Alireza Soleimani Mamalo, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 15
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Jinze Shen, Qurui Wang, Yunan Mao, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy
Kiavash Hushmandi, Behzad Einollahi, Seyed Hassan Saadat, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101952-101952
Open Access | Times Cited: 11
Mechanistic insights into circRNA-mediated regulation of PI3K signaling pathway in glioma progression
Alireza Mafi, Seyedeh Mahdieh Khoshnazar, Amirhossein Shahpar, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155442-155442
Closed Access | Times Cited: 11
Current state of immune checkpoints therapy for glioblastoma
He Wang, Jing Yang, Xiangjun Li, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24729-e24729
Open Access | Times Cited: 8
A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: from molecular interactions to potential therapeutic targets
Mina Alimohammadi, Payman Rahimzadeh, Ramin Khorrami, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155401-155401
Closed Access | Times Cited: 8
NK Cell Exosomes Alleviate PD-L1 Expression and Facilitate Tumor Immunity by Repressing PI3K-AKT-mTOR Signaling
Hang Xie, Yujie Wu, Jingyao Huang, et al.
Immunological Investigations (2025), pp. 1-14
Closed Access | Times Cited: 1
Histone lactylation promotes multidrug resistance in hepatocellular carcinoma by forming a positive feedback loop with PTEN
Yuan Zeng, Haoran Jiang, Zhoufeng Chen, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway
Hui Shao, Jingyan Chen, Ali Li, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 8, pp. 5217-5237
Open Access | Times Cited: 17
The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways
Alireza Mafi, Neda Hedayati, Samaneh Kahkesh, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1178-1189
Open Access | Times Cited: 7
Comprehensive analysis of lncRNA‐associated ceRNA network reveals novel potential prognostic regulatory axes in glioblastoma multiforme
Maryam Bazrgar, Seyed Amir Mirmotalebisohi, Mohsen Ahmadi, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 4
An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway
Pratibha Pandey, Sorabh Lakhanpal, Danish Mahmood, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Association of TAB2 gene polymorphism with endometrial cancer susceptibility and clinical analysis
Siyu Long, Yanyun Wang
Journal of Turkish Society of Obstetric and Gynecology (2025)
Open Access
PPP1R13L drives cervical cancer progression by suppressing p63-mediated PTEN transcription
Anjin Wang, Xuelian Liu, Ziyan Liang, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Role of Glutamate Excitotoxicity in Glioblastoma Growth and Its Implications in Treatment
Colin Moriarty, Natasha Gupta, Debanjan Bhattacharya
Cell Biology International (2025)
Open Access
MiR‐2110 induced by chemically synthesized cinobufagin functions as a tumor‐metastatic suppressor via targeting FGFR1 to reduce PTEN ubiquitination degradation in nasopharyngeal carcinoma
Shiyi Fang, Lanzhu Peng, Mengmin Zhang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3548-3562
Open Access | Times Cited: 4
PTEN: an emerging target in rheumatoid arthritis?
Zhou Pan, Xingwen Meng, Zhimin Nie, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas
Abdou-samad Kone, Amina Ghouzlani, Ahmed Qandouci, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
A Synopsis of Biomarkers in Glioblastoma: Past and Present
Ligia Gabriela Tătăranu, Şerban Turliuc, Radu Eugen Rizea, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6903-6939
Open Access | Times Cited: 3
PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation
Sahar Rezaei, Negin Nikpanjeh, Aryan Rezaee, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175909-175909
Closed Access | Times Cited: 7
Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma
Tongxuan Guo, Changyong Wu, Junhao Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner
Jinna Liang, Panpan Lei, Xinyue Su, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 11, pp. 1157-1168
Closed Access | Times Cited: 2
The role of IL-17 in the pathogenesis and treatment of glioblastoma—an update on the state of the art and future perspectives
Dariusz Łaszczych, Aleksandra Czernicka, Karol Gostomczyk, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top